R.PR
REGISTERED-PRINCIPAL REGISTER
11/23/2021
Back to search
Official data from USPTO
SDARBODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
11/23/2021
Trademark type
Combined
Nice classes
42
Filing date
07/13/2020
Registration date
11/23/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/23/2021
Last transaction
11/23/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/18/2021
First use in commerce
06/18/2021
Drawing code
3
Owner type
99
Owner location
Wuxi, Jiangsu, CN
Examiner
WHEATLEY, TRAVIS
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "SDARBODY" wherein the stylized letter "A" contains a shooting star going from the right lower leg in green and blue colors towards the top of the same letter, and the stylized letter "Y" is a combination of two different color (blue middle to right and green lower right and upper left) emanating upwards; otherwise, the wording "SDAR" is blue and the wording "BODY" is green.
Holders and representatives
Holders
WuXi Biologics Co., Ltd.
Representatives
Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Biomedical research services; development of pharmaceutical preparations and medicines; Research and development of antibodies
Publications
History of USPTO decisions and trademark events.
32 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/22/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/21/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/23/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/22/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
09/22/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/20/2021
IUAF
USE AMENDMENT FILED
09/13/2021
DRRR
DIVISIONAL REQUEST RECEIVED
09/13/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/13/2021
EISU
TEAS STATEMENT OF USE RECEIVED
09/13/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2021
PUBO
PUBLISHED FOR OPPOSITION
01/19/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/08/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/08/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/28/2020
GNFR
FINAL REFUSAL E-MAILED
11/28/2020
CNFR
FINAL REFUSAL WRITTEN
11/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/27/2020
GNRT
NON-FINAL ACTION E-MAILED
09/27/2020
CNRT
NON-FINAL ACTION WRITTEN
09/27/2020
DOCK
ASSIGNED TO EXAMINER
09/13/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2020
NWAP
NEW APPLICATION ENTERED
07/16/2020
Continuous trademark protection
Get notified about every new filing that threatens SDARBODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.